No data to show
XNAS
ADGM
Market cap9mUSD
Jun 26, Last price
1.26USD
1D
-0.79%
1Q
34.06%
IPO
-86.08%
Name
ARYA Sciences Acquisition Corp IV
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-2m
L
CFO
-726k
L+49.60%
Profile
ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | ||||
Cost of revenue | 9,500 | 1,009 | ||
Unusual Expense (Income) | ||||
NOPBT | (9,500) | (1,009) | ||
NOPBT Margin | ||||
Operating Taxes | (2,077) | |||
Tax Rate | ||||
NOPAT | (9,500) | 1,067 | ||
Net income | (2,133) -167.85% | 3,144 -147.91% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | (115,072) | (45) | ||
BB yield | ||||
| Debt | ||||
Debt current | 2,175 | 120 | ||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | 2,616 | 2,616 | ||
Net debt | (38,421) | (151,600) | ||
| Cash flow | ||||
Cash from operating activities | (726) | (485) | ||
CAPEX | ||||
Cash from investing activities | 113,672 | |||
Cash from financing activities | (113,017) | 75 | ||
FCF | (5,533) | 1,957 | ||
| Balance | ||||
Cash | 20 | 91 | ||
Long term investments | 40,576 | 151,629 | ||
Excess cash | 40,596 | 151,720 | ||
Stockholders' equity | 25,683 | 142,888 | ||
Invested Capital | 4,922 | 2,736 | ||
ROIC | 26.79% | |||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 9,809 | 19,186 | ||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | (9,500) | (1,009) | ||
EV/EBITDA | ||||
Interest | 2,077 | |||
Interest/NOPBT | ||||